Try our Advanced Search for more refined results
Unichem Pharmaceuticals USA Inc.
-
Order | Filed: June 06, 2023 | Entered: June 07, 2023 ASTRAZENECA AB et al v. UNICHEM LABORATORIES LIMITED et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Order of Dismissal
CONSENT JUDGMENT dismissing all claims, counterclaims, affirmative defenses, and demands in this action with prejudice and without costs, disbursements or attorneys' fees to any party. Signed by Judge Karen M. Williams on 6/6/2023. (alb, )
-
Misc | Filed: June 02, 2023 | Entered: June 02, 2023 ASTRAZENECA AB et al v. UNICHEM LABORATORIES LIMITED et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Letter
Letter from Plaintiffs to Hon. Karen M. Williams, U.S.D.J., re consent judgment. (Attachments: # 1 Text of Proposed Order)(BETZ, CYNTHIA)
-
Order | Filed: May 09, 2023 | Entered: May 09, 2023 ASTRAZENECA AB et al v. UNICHEM LABORATORIES LIMITED et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Order
LETTER ORDER granting Defendants request for 30 day extension to answer, move, or otherwise respond to 1 Plaintiff's Complaint, until June 5, 2023. Signed by Magistrate Judge Elizabeth A. Pascal on 5/8/2023. (alb)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login